Piccini, J. P., Hellkamp, A. S., Mahaffey, K. W., Berkowitz, S. D., Nessel, C. C., Becker, R. C., … Patel, M. R. (2014). Polypharmacy and the Efficacy and Safety of Rivaroxaban versus Warfarin in the Prevention of Stroke: Results From the ROCKET AF Trial. CIRCULATION, 130.

Piccini, Jonathan P., Anne S. Hellkamp, Kenneth W. Mahaffey, Scott D. Berkowitz, Christopher C. Nessel, Richard C. Becker, Jonathan L. Halperin, et al. “Polypharmacy and the Efficacy and Safety of Rivaroxaban versus Warfarin in the Prevention of Stroke: Results From the ROCKET AF Trial.” CIRCULATION 130 (November 25, 2014).

Piccini JP, Hellkamp AS, Mahaffey KW, Berkowitz SD, Nessel CC, Becker RC, et al. Polypharmacy and the Efficacy and Safety of Rivaroxaban versus Warfarin in the Prevention of Stroke: Results From the ROCKET AF Trial. CIRCULATION. 2014 Nov 25;130.

Piccini, Jonathan P., et al. “Polypharmacy and the Efficacy and Safety of Rivaroxaban versus Warfarin in the Prevention of Stroke: Results From the ROCKET AF Trial.” CIRCULATION, vol. 130, LIPPINCOTT WILLIAMS & WILKINS, Nov. 2014.

Piccini JP, Hellkamp AS, Mahaffey KW, Berkowitz SD, Nessel CC, Becker RC, Halperin JL, Hacke W, Singer DE, Hankey GJ, Breithardt G, Fox KA, Califf RM, Patel MR. Polypharmacy and the Efficacy and Safety of Rivaroxaban versus Warfarin in the Prevention of Stroke: Results From the ROCKET AF Trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2014 Nov 25;130.